New Research Into the Benefits of Collagen Peptides in Countering Sarcopenia
04 Dec 2015 | Gelita
To fight sarcopenia GELITA has developed specific bioactive collagen peptides named BODYBALANCE. Now a double blind placebo controlled study was performed at the Institute of Sports and Sports Science at the University of Freiburg, Germany, that included 60 sarcopenic men aged 65 and older, with a mean age of 72 years. It is the first study that investigates the effects of collagen peptides on body composition and muscle strength.
